DERMATOFIBROMA OF THE GREAT TOE – A RARE CASE REPORT

Surya Rao Rao Venkata Mahipathy, Arjunan Babu Lakshmanan, Susruthan Murali

Abstract


Dermatofibroma (DF), also referred to as cutaneous fibrous histiocytoma (CFH), is a common benign tumor of the skin presenting as a firm nodule located predominantly on the limbs and shoulder and pelvic girdles that often extends into superficial subcutaneous tissue.Dermatofibroma has many clinicopathological variants. This report presents a case of a dermatofibroma on a great toe that had been slowly growing for four years. Histopathologically, the relatively well-circumscribed dermal tumor was separated from the epidermis by a small grenz zone. The tumor tissue consisted of spindle-shaped cells with well-defined cell borders and spindly condensed nuclei. No cytologic atypia or mitotic figures were found. Immunohistochemically, the tumor cells showed negative staining for CD34 and S-100. Histopathological differential diagnoses of dermatofibroma include superficial acral fibromyxoma, cellular digital fibroma, superficial angiomyxoma, myxoid dermatofibrosarcoma protuberans and low-grade fibromyxoid sarcoma. Immunohistochemical staining can be useful in the differential diagnosis of these tumors. Pathologists should keep in mind the diagnosis of dermatofibroma when dealing with circumscribed, firm nodules presenting on the digits

Keywords


Benign, Dermatofibroma, Rare, Surgical Excision

Full Text:

PDF

References


Calikoglu E, Chavaz P, Saurat JH, Kaya G. Decreased CD44 expression and stromal hyaluronate accumulation in myxoid dermatofibroma. Dermatology. 2003;207:104–106.

Zelger BG, Calonje E, Zelger B. Myxoid dermatofibroma. Histopathology. 1999;34:357–364.

Weiss SW, Goldblum JR. Fibrous Histiocytoma In: Weiss SW, Goldblum JR, editors. Enzinger and Weiss' Soft Tissue Tumors, 5th Edition. Philadelphia (PA): Mosby Elsevier; 2008. p. 1121-32.

Weedon D. Chapter 34: Tumors and tumor-like proliferations of fibrous and related tissues In: Weedon D, editor. Weedon's Skin Pathology, Third Edition. China: Churchill-Livingston-Elsevier; 2010. p. 827.

Gonzalez S, Duarte I. Benign fibrous histiocytoma of the skin. A morphologic study of 290 cases. Pathol Res Pract. 1982;174:379–391.

Schwob VS, Santa Cruz DJ. Palisading cutaneous fibrous histiocytoma. J Cutan Pathol. 1986;13:403–407.

Yamamoto T, Umeda T, Nishioka K. Dermatofibroma of the digit: report of six cases. Dermatology. 2003;207:79–81.

Yamamoto T, Yokoyama A, Katayama I, Nishioka K. Dermatofibroma with myxoid changes in a patient with psoriasis. J Dermatol. 1995;22:780–783.

Calonje E, Fletcher C. Review article: cutaneous fibrohistiocytic tumors: an update. Adv Anatom Pathol 1994; 1(1): 2-15.

Calonje E, Mentzel T, Fletcher C. Cellular benign fibrous histiocytoma: clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence. Am J Surg Pathol 1994; 18(7): 668-676.

McCabe J, Blades Z, McGrath E. Practice: What is your call? Canadian Med Assoc J 2008;179(12):1297-1299.

Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol. 1993;17:1039–1045.

Guitart J, Ramirez J, Laskin WB. Cellular digital fibromas: what about superficial acral fibromyxoma? J Cutan Pathol. 2006;33:762–763. author reply 764.

McNiff JM, Subtil A, Cowper SE, Lazova R, Glusac EJ. Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans. J Cutan Pathol. 2005;32:413–418.

van Roggen JF, McMenamin ME, Fletcher CD. Cellular myxoma of soft tissue: a clinicopathological study of 38 cases confirming indolent clinical behaviour. Histopathology. 2001;39:287–297.

Andre J, Theunis A, Richert B, de Saint-Aubain N. Superficial acral fibromyxoma: clinical and pathological features. Am J Dermatopathol. 2004;26:472–474.

Carranza C, Molina-Ruiz AM, Perez de la Fuente T, Kutzner H, Requena L, Santonja C. Subungual acral fibromyxoma involving the bone: a mimicker of malignancy. Am J Dermatopathol. 2015;37:555–9.

Kazlouskaya V, Malhotra S, Kabigting FD, Lal K, Elston DM. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma. Am J Dermatopathol. 2014;36:392–396.


Refbacks

  • There are currently no refbacks.